Delivery Order SPE2DB22D3010-SPE2DB24FP1SW
- Not listed
- Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4563479231 - Bupropion XL 300mg 500S pharmaceutical product. The contract has a completion date of January 31, 2024 and a potential value of $1,727.73. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is placed...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide $7,463.64 worth of BUPROPION HCL XL 150 MG TABLET 500S. This order is part of a larger $999,999,999.00 indefinite delivery contract that serves as the primary vehicle for Amerisourcebergen to supply pharmaceuticals and medical supplies to DLA Troop Support...
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564034116 - Bupropion HCL XL 300 mg Tablets in 500 count packages. The contract has a ceiling value of $5,364.72 and a performance period through March 22, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger $999,999,999.00 indefinite delivery...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $1,814.29, is for the supply of Bupropion HCL XL 300 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract (SPE2DB22D2009|SPE2DB24FL9CK) by the Defense Logistics Agency (DLA) Troop Support Medical to supply 4564234898 ! BUPROPION HCL XL 150 MG TABLET 500S. The contract has a total ceiling value of $12,937.17 and a period of performance through April 11, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $37,884.80 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4564205437 - Bupropion HCL XL 300 mg tablets in 500 count bottles. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,981,495 units of Bupropion HCl XL 300 mg tablets. The $3,363.79 contract has a period of performance through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
- The U.S. government awarded a $18,459.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,247,360 units of Bupropion HCL XL 300 mg tablets. The contract, with a completion date of April 12, 2024, was issued by the Defense Logistics Agency (DLA) Troop Support Medical under an existing indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of up to...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,311,946 units of the pharmaceutical product Bupropion HCl XL 300 mg Tablet. The contract has a ceiling value of $36,539.49 and a period of performance through April 18, 2024. This award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive...
- This federal contract award, valued at $5,673.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 4564186178 BUPROPION HCL XL 300 MG TABLET 500S, a generic pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an Indefinite Delivery Contract (IDC) awarded by...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB24FP1SWDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $10,662.46 by the Defense Logistics Agency (DLA) to provide 4,563,690,130 units of the pharmaceutical product BUPROPION HCL XL 300 MG TABLET. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 2/16/24 |